The TID data seem better here then the BID, though I am not sure if they are stat sig. In the prior trial I don't believe TID showed a benefit.
The importance to pointing it out is relevance to XNPT's program. Regardless I think they have to get their compound to qD since the drug seems to be fairly well tolerated in these studies.
Market Data 
Markets 
AI
